C3TI aims to increase experience in Bayesian statistical methods in simple trial settings across sponsors, CDER clinical reviewers, and CDER statisticians, including deepening an understanding of their applicability, opportunities, and challenges.
Similar Posts
Fulijaya Manufacturing SDN. BHD. – 719172 – 01/14/2026
CGMP/Finished Pharmaceuticals/AdulteratedAdvancing Clinical Trial Participation for the LGBTQIA+ Community
Representatives of the FDA were fortunate to attend a community discussion on advancing clinical trial diversity for sexual and gender minority communities to help improve the generalizability of trial results across the entire population of patients who may use medical products.Prime Food Processing LLC Issues Allergy Alert and Safety Warning Regarding Uneviscerated Dried Croaker Fish
Brooklyn, NY – Prime Food Processing LLC is voluntarily recalling Dried Croaker Fish because the product was not adequately eviscerated, as required by the U.S. Food and Drug Administration (FDA). Fish that are not properly eviscerated mayUpdate on the Safety of Andexxa by AstraZeneca: FDA Safety Communication
Since approval, the FDA has received postmarketing safety data on thromboembolic events, including serious and fatal outcomes, in patients treated with Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo). Based on available data, the serious risks including the increase in thromboembolicZydus Lifesciences Limited – 9/5/2025
Zydus Lifesciences Limited – 9/5/2025. Country: India. Record Type: 483Cosmetic Manufacturers Pty Ltd. – 719225 – 02/06/2026
CGMP/Finished Pharmaceuticals/Adulterated